SB 5883 was passed on June 30, 2017 mandating that all MCOs and WA FFS utilize a single preferred drug list (PDL) on or before January 1, 2018. The single PDL will ensure continuity of formulary and criteria for coverage across all MCOs and FFS.
The goal is to ensure access to clinically effective and appropriate drug therapies while maximizing rebates to the state. CHPW pharmacy is working with the HCA in the development of both the future PDL and the criteria for coverage. The HCA is developing a communication strategy to update providers and pharmacies of changes as they roll out. CHPW will also be alerting you to upcoming changes as they are finalized.